Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited, a prominent player in the Indian pharmaceutical industry, is headquartered in New Delhi, India. Founded in 1986, the company has established itself as a key provider of high-quality pharmaceutical products, focusing on areas such as analgesics, anti-infectives, and cardiovascular medications. Jagsonpal is renowned for its commitment to innovation and quality, offering a diverse range of formulations that cater to both domestic and international markets. The company’s unique approach to research and development has led to several notable achievements, positioning it as a trusted name in healthcare. With a strong presence across various operational regions, Jagsonpal Pharmaceuticals continues to enhance its market position through strategic partnerships and a robust product portfolio.
DitchCarbon Score
How does Jagsonpal Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jagsonpal Pharmaceuticals Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jagsonpal Pharmaceuticals Limited's reported carbon emissions
Jagsonpal Pharmaceuticals Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Jagsonpal Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate action. However, without specific emissions data or reduction initiatives, it is challenging to assess Jagsonpal Pharmaceuticals' position relative to its peers in terms of environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jagsonpal Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
